Award Year / Program / Phase:1984 / SBIR / Phase I
Agency:HHS
Principal Investigator:Dr. gerald entine , PRESIDENT
Award Amount:$49,923.00
Abstract:
I. specific aims a. introduction - one of the most exciting approaches to the treatment of lympocytic malignancies is the use of monoclonal anti--idiotypic antibodies directed against the surface immunoglobulin of malignant b lymphocytes. such reagents combine with malignant lymphocytes but not with… More
Award Year / Program / Phase:1985 / SBIR / Phase II
Agency:HHS
Principal Investigator:Gerald Entine Ph.d.
Award Amount:$237,436.00
Abstract:
"electronic cell fusion technique for hybridomas" sbir - div. of res. resources and/or niaid - immunology. the production of hybridomas by cell fusion is an increasingly important aspect of both research and clinical protocols. almost all fusions are done with techniques which have low absolute… More